PKM and breast cancer: Specifically, we found that YTHDF1 had a strong binding ability to the mRNA of PKM2 in breast cancer cell, which is a key enzyme in the glycolysis pathway and responsible for high glycolytic metabolism of YTHDF1-overexpressing tumors.